Applications of deep learning techniques for automated multiple sclerosis detection using magnetic resonance imaging: A review

A Shoeibi, M Khodatars, M Jafari, P Moridian… - Computers in Biology …, 2021 - Elsevier
Multiple Sclerosis (MS) is a type of brain disease which causes visual, sensory, and motor
problems for people with a detrimental effect on the functioning of the nervous system. In …

Epidemiology and treatment of multiple sclerosis in elderly populations

CB Vaughn, D Jakimovski, KS Kavak… - Nature Reviews …, 2019 - nature.com
The prevalence of multiple sclerosis (MS) and the age of affected patients are increasing
owing to increased longevity of the general population and the availability of effective …

MAGNIMS consensus recommendations on the use of brain and spinal cord atrophy measures in clinical practice

J Sastre-Garriga, D Pareto, M Battaglini… - Nature Reviews …, 2020 - nature.com
Early evaluation of treatment response and prediction of disease evolution are key issues in
the management of people with multiple sclerosis (MS). In the past 20 years, MRI has …

Advances in spinal cord imaging in multiple sclerosis

M Moccia, S Ruggieri, A Ianniello… - Therapeutic …, 2019 - journals.sagepub.com
The spinal cord is frequently affected in multiple sclerosis (MS), causing motor, sensory and
autonomic dysfunction. A number of pathological abnormalities, including demyelination …

Diagnosis of progressive multiple sclerosis from the imaging perspective: a review

M Filippi, P Preziosa, F Barkhof, DT Chard… - JAMA …, 2021 - jamanetwork.com
Importance Although magnetic resonance imaging (MRI) is useful for monitoring disease
dissemination in space and over time and excluding multiple sclerosis (MS) mimics, there …

Current and future role of MRI in the diagnosis and prognosis of multiple sclerosis

MA Rocca, P Preziosa, F Barkhof… - The Lancet Regional …, 2024 - thelancet.com
In the majority of cases, multiple sclerosis (MS) is characterized by reversible episodes of
neurological dysfunction, often followed by irreversible clinical disability. Accurate diagnostic …

Determinants and biomarkers of progression independent of relapses in multiple sclerosis

M Calabrese, P Preziosa, A Scalfari… - Annals of …, 2024 - Wiley Online Library
Clinical, pathological, and imaging evidence in multiple sclerosis (MS) suggests that a
smoldering inflammatory activity is present from the earliest stages of the disease and …

Blood neurofilament light in progressive multiple sclerosis: post hoc analysis of 2 randomized controlled trials

D Leppert, H Kropshofer, DA Häring, F Dahlke, A Patil… - Neurology, 2022 - AAN Enterprises
Background and Objectives To investigate the potential of plasma neurofilament light (pNfL)
as a biomarker of disease progression and treatment response in progressive multiple …

Volume loss in the deep gray matter and thalamic subnuclei: a longitudinal study on disability progression in multiple sclerosis

S Magon, C Tsagkas, L Gaetano, R Patel… - Journal of …, 2020 - Springer
Background Volume loss in the deep gray matter (DGM) has been reported in patients with
multiple sclerosis (MS) already at early stages of the disease and is thought to progress …

Clinically relevant cranio-caudal patterns of cervical cord atrophy evolution in MS

MA Rocca, P Valsasina, A Meani, C Gobbi, C Zecca… - Neurology, 2019 - AAN Enterprises
Objective To characterize the distribution and regional evolution of cervical cord atrophy in
patients with multiple sclerosis (MS) in a multicenter dataset. Methods MRI and clinical …